BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37129249)

  • 1. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
    Spinazzola E; Quattrone D; Rodriguez V; Trotta G; Alameda L; Tripoli G; Gayer-Anderson C; Freeman TP; Johnson EC; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Galatolo M; Tortelli A; Tagliabue I; Turco M; Pompili M; Selten JP; de Haan L; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; O'Donovan M; Rutten BP; Van Os J; Morgan C; Sham PC; Austin-Zimmerman I; Li Z; Vassos E; ; Murray RM; Di Forti M
    Psychol Med; 2023 Nov; 53(15):7418-7427. PubMed ID: 37129249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
    Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
    Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
    Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
    Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
    Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
    Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.
    Ricci V; Ceci F; Di Carlo F; Lalli A; Ciavoni L; Mosca A; Sepede G; Salone A; Quattrone D; Fraticelli S; Maina G; Martinotti G
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109118. PubMed ID: 34688166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls.
    Sami M; Quattrone D; Ferraro L; Tripoli G; Cascia E; Gayer-Anderson C; Selten JP; Arango C; Bernardo M; Tarricone I; Tortelli A; Gatto G; Del Peschio S; Del-Ben CM; Rutten BP; Jones PB; van Os J; de Haan L; Morgan C; Lewis C; Bhattacharyya S; Freeman TP; Lynskey M; Murray RM; Forti MD
    Psychol Med; 2021 Sep; 51(12):2074-2082. PubMed ID: 32340643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and Psychosis: a Critical Overview of the Relationship.
    Ksir C; Hart CL
    Curr Psychiatry Rep; 2016 Feb; 18(2):12. PubMed ID: 26781550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
    Quattrone D; Reininghaus U; Richards AL; Tripoli G; Ferraro L; Quattrone A; Marino P; Rodriguez V; Spinazzola E; Gayer-Anderson C; Jongsma HE; Jones PB; La Cascia C; La Barbera D; Tarricone I; Bonora E; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Arrojo M; Tortelli A; Velthorst E; Berendsen S; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Kirkbride JB; Sham PC; O'Donovan MC; Cardno AG; Vassos E; van Os J; Morgan C; Murray RM; Lewis CM; Di Forti M;
    Transl Psychiatry; 2021 Aug; 11(1):423. PubMed ID: 34376640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use.
    Sideli L; Fisher HL; Murray RM; Sallis H; Russo M; Stilo SA; Paparelli A; Wiffen BDR; O'Connor JA; Pintore S; Ferraro L; La Cascia C; La Barbera D; Morgan C; Di Forti M
    Early Interv Psychiatry; 2018 Apr; 12(2):135-142. PubMed ID: 26560802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.
    Myles H; Myles N; Large M
    Aust N Z J Psychiatry; 2016 Mar; 50(3):208-19. PubMed ID: 26286531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study.
    Jongsma HE; Gayer-Anderson C; Tarricone I; Velthorst E; van der Ven E; Quattrone D; di Forti M; ; Menezes PR; Del-Ben CM; Arango C; Lasalvia A; Berardi D; La Cascia C; Bobes J; Bernardo M; Sanjuán J; Santos JL; Arrojo M; de Haan L; Tortelli A; Szöke A; Murray RM; Rutten BP; van Os J; Morgan C; Jones PB; Kirkbride JB
    Psychol Med; 2021 Jul; 51(9):1536-1548. PubMed ID: 32122439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.
    Grossman M; Bowie CR; Lepage M; Malla AK; Joober R; Iyer SN
    J Psychiatr Res; 2017 Feb; 85():83-90. PubMed ID: 27863280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use and psychosis: a longitudinal population-based study.
    van Os J; Bak M; Hanssen M; Bijl RV; de Graaf R; Verdoux H
    Am J Epidemiol; 2002 Aug; 156(4):319-27. PubMed ID: 12181101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.